Endogenous hormones and bone turnover markers in pre- and perimenopausal women: SWAN
dc.contributor.author | Ettinger, B. | en_US |
dc.contributor.author | Bondarenko, I. | en_US |
dc.contributor.author | Greendale, Gail A. | en_US |
dc.contributor.author | Cauley, J. A. | en_US |
dc.contributor.author | Neer, R. M. | en_US |
dc.contributor.author | Finkelstein, Joel S. | en_US |
dc.contributor.author | Sowers, MaryFran R. | en_US |
dc.date.accessioned | 2006-09-08T19:43:06Z | |
dc.date.available | 2006-09-08T19:43:06Z | |
dc.date.issued | 2003-03 | en_US |
dc.identifier.citation | Sowers, M. R.; Greendale, G. A.; Bondarenko, I.; Finkelstein, J. S.; Cauley, J. A.; Neer, R. M.; Ettinger, B.; (2003). "Endogenous hormones and bone turnover markers in pre- and perimenopausal women: SWAN." Osteoporosis International 14(3): 191-197. <http://hdl.handle.net/2027.42/41863> | en_US |
dc.identifier.issn | 0937-941X | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/41863 | |
dc.identifier.uri | http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=12730778&dopt=citation | en_US |
dc.description.abstract | We tested the hypothesis that higher serum osteocalcin and urinary N-telopeptide of type I collagen (NTx) concentrations would be found in women with increasing cycle irregularity or increased follicle stimulating hormone concentrations. We studied 2,375 pre- and early perimenopausal women from the Study of Women's Health Across the Nation (SWAN), aged 42–52 years, who self-identified their race/ethnic origin as African-American (28.3%), Caucasian (49.4%), Japanese (10.5%) or Chinese (11.8%). Outcome measures were serum osteocalcin, a measure of bone formation, and NTx, a measure of bone resorption. The explanatory variables were menopausal status, based on self-reported regularity of menstrual bleeding, and circulating endogenous hormone concentrations including estradiol (E 2 ), testosterone (T), sex hormone binding globulin (SHBG) and follicle stimulating hormone (FSH) concentrations. Additionally, we evaluated the association of the bone turnover markers with the Free Androgen Index (FAI) and the Free Estradiol Index (FEI), ratios of total testosterone and estradiol concentrations to SHBG, respectively. Higher FSH concentrations were associated with higher NTx concentrations ( β =0.003, partial r 2 =2.1%, p <0.0001), both before and after adjusting for other covariates (total explained variability of 9%). Higher FSH concentrations were also associated with higher osteocalcin concentrations ( β =−0.216, partial r 2 =4.1%, p <0.0001, total explained variability of 15.4%). There were no significant associations of the bone turnover markers with other endogenous hormones, following adjustment for covariates. Mean osteocalcin and NTx values were not significantly different in premenopausal women compared to early perimenopausal women. In these pre- and early perimenopausal women, higher FSH concentrations, but not other serum reproductive hormone concentrations, are positively associated with greater bone turnover prior to the last menstrual period. | en_US |
dc.format.extent | 216546 bytes | |
dc.format.extent | 3115 bytes | |
dc.format.mimetype | application/pdf | |
dc.format.mimetype | text/plain | |
dc.language.iso | en_US | |
dc.publisher | Springer-Verlag; International Osteoporosis Foundation and National Osteoporosis Foundation | en_US |
dc.subject.other | Estrogen Follicle Stimulating Hormone N-telopeptides Osteocalcin Perimenopause | en_US |
dc.subject.other | Legacy | en_US |
dc.title | Endogenous hormones and bone turnover markers in pre- and perimenopausal women: SWAN | en_US |
dc.type | Article | en_US |
dc.subject.hlbsecondlevel | Obstetrics and Gynecology | en_US |
dc.subject.hlbsecondlevel | Internal Medicine and Specialties | en_US |
dc.subject.hlbtoplevel | Health Sciences | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.contributor.affiliationum | Rm 2624, SPH-1, Department of Epidemiology, School of Public Health, University of Michigan, 109 Observatory Street, Ann Arbor, MI 48109-2029, USA, | en_US |
dc.contributor.affiliationum | Rm 2624, SPH-1, Department of Epidemiology, School of Public Health, University of Michigan, 109 Observatory Street, Ann Arbor, MI 48109-2029, USA, | en_US |
dc.contributor.affiliationother | Division of Geriatrics, UCLA School of Medicine, Los Angeles, CA 90095, USA, | en_US |
dc.contributor.affiliationother | Division of Research, Kaiser Permanente Medical Care Program, Oakland, CA 94611, USA, | en_US |
dc.contributor.affiliationother | Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA 15213, USA, | en_US |
dc.contributor.affiliationother | Endocrine Unit, Department of Medicine, Massachusetts General Hospital, Boston, MA 02114, USA, | en_US |
dc.contributor.affiliationother | Endocrine Unit, Department of Medicine, Massachusetts General Hospital, Boston, MA 02114, USA, | en_US |
dc.contributor.affiliationumcampus | Ann Arbor | en_US |
dc.identifier.pmid | 12730778 | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/41863/1/s00198-002-1329-4.pdf | en_US |
dc.identifier.doi | http://dx.doi.org/10.1007/s00198-002-1329-4 | en_US |
dc.identifier.source | Osteoporosis International | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe its collections in a way that respects the people and communities who create, use, and are represented in them. We encourage you to Contact Us anonymously if you encounter harmful or problematic language in catalog records or finding aids. More information about our policies and practices is available at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.